The New Zealand Multiple Sclerosis Research Trust (“NZMSRT”) today announces it has received a combined $900,000 investment portfolio as founding capital for the Trust.
A $600,000 portfolio has been transferred from the Multiple Sclerosis Society of New Zealand and a $300,000 portfolio from the Multiple Sclerosis Auckland Region Trust.
The Research Trust has been established to stimulate, co-ordinate and support New Zealand-based research into the cause, prevention, treatment, alleviation and cure of Multiple Sclerosis (MS), and to obtain and disseminate research findings.
To read the full release, click on the following link NZMSRT launch release